1.
Santamaria A, Martinez-Rubio A, Borrell M, Mateo J, Ortin R, Fontcuberta J. Risk of acute coronary artery disease associated with functional thrombin activatable fibrinolysis inhibitor plasma level. Haematologica [Internet]. 2004Jul.1 [cited 2026Nov.8];89(7):880-1. Available from: https://haematologica.org/article/view/3161